Showing 3021-3030 of 3223 results for "".
- Market Scope: Booming Demand, Surgical Planning Integration Drive Growth in Ophthalmic Diagnostic Markethttps://modernod.com/news/market-scope-booming-demand-surgical-planning-integration-drive-growth-in-ophthalmic-diagnostic-market/2476723/Market Scope estimates that the ophthalmic diagnostic equipment market will total $3.2 billion in 2019, and the firm expects it to increase to $3.8 billion in 2024—for a compound annual growth rate of 3.9 percent. Contributing factors include a rising global population, with an expanding elderly
- Small Percentage of Ophthalmologists Perform Large Proportion of Intravitreal Anti-VEGF Injectionshttps://modernod.com/news/small-percentage-of-ophthalmologists-perform-large-proportion-of-intravitreal-anti-vegf-injections/2476712/Three percent of ophthalmologists perform 17% to 31% of all anti-vascular endothelial growth factor (VEGF) injections in the U.S., depending on the agent used, according to new findings, as reported by Reuters. “More important
- PlanetVA Launches Eyewear Virtual Try-On Platform That Creates a 3D Face Model From Selfiehttps://modernod.com/news/planetva-launches-eyewear-virtual-try-on-platform-that-creates-a-3d-face-model-from-selfie/2476684/PlanetVA announced the launch of its latest eyewear virtual try-on platform: vmPRO. By just taking a selfie, the app creates a 3D face model of the user in just a matter of seconds. This app leverages current augmented reality trends and the latest artificial intelligence algorithms to allow th
- RightEye, USA Baseball and Optometrists Team Up to Improve Players’ Athletic Abilities Through Sports Visionhttps://modernod.com/news/righteye-usa-baseball-and-optometrists-team-up-to-improve-players-athletic-abilities-through-sports-vision/2476677/RightEye announced that it is working with USA Baseball for the third consecutive year to provide baseline sports vision assessment to all athletes entering the Prospect Development Pipeline (PDP), a collaboration bet
- EyecareLive Unveils Enhanced Responsible Telemedicine Platform for Optometry and Ophthalmologyhttps://modernod.com/news/eyecarelive-unveils-enhanced-responsible-telemedicine-platform-for-optometry-and-ophthalmology/2476674/EyecareLive announced the release of EyecareLive 2.0. EyecareLive was built by doctors, for doctors, with a mission to strengthen the doctor-patient relationship by providing a comprehensive telemedicine platform that enhances patient care. The launch will also feature EyecareLive’s
- UK’s First TransForm Inlay Procedure Performed by Sheraz Daya, MDhttps://modernod.com/news/uks-first-transform-inlay-procedure-performed-by-sheraz-daya-md/2476668/The first patients in the UK have undergone the TransForm Corneal Allograft (TCA) procedure, which was performed by Sheraz Daya, MD, FACP, FACS, FRCS(Ed), FRCOphth. TCA is a new procedur
- House Subcommittee Urges FTC to Modernize Contact Lens Verification Processhttps://modernod.com/news/house-subcommittee-urges-ftc-to-modernize-contact-lens-verification-process/2476657/The Health Care Alliance for Patient Safety expressed its support of the House Committee on Appropriations for urging the Federal Trade Commission (FTC) to update the process by which contact lens prescriptions are verified, according to a news
- SightLife Announces 100,000 Corneal Transplants in India Since Program Inception in 2009https://modernod.com/news/sightlife-announces-100000-corneal-transplants-in-india-since-program-inception-in-2009/2476639/SightLife announced that, together with its partners in India, 100,000 individuals suffering from corneal blindness have had their sight restored through a corneal transplant in the last 10 years since operations began in India. SightLife is a nonprofit global health organization dedicated to eli
- Three-Year Clinical Trial Results Support Iluvien Launch in Europe for Prevention of Relapse in Recurrent Noninfectious Uveitis Affecting the Posterior Segmenthttps://modernod.com/news/three-year-clinical-trial-results-support-iluvien-launch-in-europe-for-prevention-of-relapse-in-recurrent-noninfectious-uveitis-affecting-the-posterior-segment/2476635/Alimera Sciences announced 3-year followup data from the phase 3 clinical trial for Iluvien 190 micrograms intravitreal implant in applicator for the prevention of relapse in recurrent noninfectious uveitis affecting the posterior segment of the eye (NIPU). The data will support the company’s pla
- FDA Wins Case Against Florida Stem Cell Clinic that Harmed three Women’s Visionhttps://modernod.com/news/fda-wins-case-against-florida-stem-cell-clinic-that-harmed-three-womens-vision/2476631/The FDA has won a federal judge’s backing for its efforts to crack down on the rapidly growing stem cell industry that promises all kinds of unproven treatments for serious diseases, according to an NBC News